Responsive Image

 

 

Responsive Image

Cáncer hematológico

Líneas de investigación

Diagnóstico de infecciones fúngicas invasivas.
Tratamiento de hemopatías malignas.
Trasplante de progenitores hematopoyéticos.
Sobrecarga férrica.
Terapia celular.

Foto grupo

Actividades del grupo

El Grupo de Cáncer Hematológico desarrolla su actividad sobre enfermedades hematológicas malignas, fundamentalmente: leucemias agudas, síndromes mielodisplásicos (SMDp) y mieloproliferativos (SMPc), linfomas y mieloma múltiple.

Esta actividad se lleva a cabo en forma de ensayos clínicos con fármacos, en distintas fases de desarrollo, estudios de registro y proyectos de investigación.

Dentro de los ensayos se incluyen el uso de midostaurin en leucemias agudas mieloides, la lenalidomida y el luspatercept en SMDp, el ruxolitinib y nilotinib en SMPc y distintos esquemas de tratamiento en linfomas y mieloma múltiple.

Los estudios de registro atienden al reporte de pacientes trasplantados al EBMT (Grupo Europeo de Trasplante de Progenitores Hematopoyéticos) y al Registro Nacional de Hemoglobinuria Paroxística Nocturna, desde donde se generan habitualmente estudios retrospectivos.

Los proyectos de investigación activos actualmente estudian el papel de las células NK y del ejercicio (EFIKRONIC) en la reconstitución inmune de pacientes sometidos a trasplantes autólogos y su papel en las recaídas.

Además, el grupo de Cáncer Hematológico pertenece al Grupo de Estudio de la Infección Fúngica Invasora de la UPV/EHU para el diagnóstico de este tipo de infección en pacientes hematológicos en situación de alto riesgo de contraerla.

Coordinador/a del grupo



Miembros del grupo

  Nagore Alonso Mediavilla
 
 
  Elena Amutio Díez
 
 
  Saioa Arambarri Uruñuela
 
 
  Olga Arce Fernández
 
 
  Beatriz Arrizabalaga Amuchastegui
 
 
  Javier Arzuaga Méndez
 
 
  Amaia Balerdi Malcorra
 
 
  Roberto Céspedes López
 
 
  María Cristina de Barrenetxea Lekue
 
 
  Rafael Andrés del Orbe Barreto
 
 
  Zuriñe Díez Gallarreta
 
 
  Ianire Etxeguren Urkixo
 
 
  Ayman Gaafar Eleraky
 
 
  Eukene Gainza González
 
 
  Fernando Marco de Lucas
 
 
  Susana Herráez Rodríguez
 
 
  José Antonio Márquez Navarro
 
 
  Xabier Martín Martitegui
 
 
  Juan José Mateos Mazón
 
 
  María Dolores Moragues Tosantos
 
  Jesús María Ojanguren Bergaz
 
 
  Matxalen Olivares Salaverri
 
 
  María Puente Pomposo
 
 
  Juan Ignacio Rodríguez Gutiérrez
 
 
  Cristina Sierra Aisa
 
 
  Jasone Uriarte Elguezabal
 
 
  Miriam Vara Pampliega
 
 
  Ana María Iglesias Pérez
 
 
  Laura Posada Alcón
 
 

Publicaciones del grupo

Galiacho VR, Arzuaga Mendez J, Fernandez Munoz H, Murga M, Amutio E, Garcia Ruiz JC. Hairy kidney in high-grade B-cell lymphoma. Int J Hematol. 2022; 115(1): 3-4. DOI:10.1007/s12185-021-03257-w.

Perez Persona E, Oiartzabal Ormategui I, Herraez S, Menchaca C, Cuevas Palomares L, Santamaria Lopez A, et al. Velcadito: Low dose of bortezomib with melphalan and prednisone for >= 75-year-olds newly diagnosed with multiple myeloma. Eur J Haematol. 2022; 108(6): 532-535. DOI:10.1111/ejh.13760.

Galiacho VR, Pomposo MP, Echebarria Barona A, Urdiales PG, Ruiz JCG. Appearances are deceiving: immature lymphocytes in Leishmaniasis. Blood Res. 2022; 57(1): 4-4. DOI:10.5045/br.2022.2021191.

Mazon MM, Caballero CMM, Mazon JJM, Negro LD, Sanz LD. Observational study of the adherence to the correct use of face masks by the general population in open public places during two periods of the COVID-19 pandemic in four Spanish cities. Rev Esp Salud Publica. 2022; 96

Martinez Cuadron D, Megias Vericat JE, Serrano J, Martinez Sanchez P, Rodriguez Arboli E, Gil C, et al. Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study. Blood Adv. 2022; 6(4): 1278-1295. DOI:10.1182/bloodadvances.2021005335.

Lopez RC, Diez EA, Martitegui XM, Malcorra AB, Oleaga LI, Arzuaga Mendez J, et al. Pure white cell aplasia an exceptional condition in the immunological conundrum of thymomas: Responses to immunosuppression and literature review. Clin Case Rep. 2022; 10(5). DOI:10.1002/ccr3.5742.

Carrasco Garcia E, Lopez L, Moncho Amor V, Carazo F, Aldaz P, Collado M, et al. SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression. Cancers (Basel). 2022; 14(4). DOI:10.3390/cancers14040916.

Alvarez Larran A, Garrote M, Ferrer Marin F, Perez Encinas M, Mata Vazquez MI, Bellosillo B, et al. Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. Cancer. 2022; 128(13): 2441-2448. DOI:10.1002/cncr.34195.

Roldan Galiacho V, Lopez Almaraz R, Zaldumbide Duenas L, Garcia Ruiz JC. Alveolar rhabdomyosarcoma with cannibalism and erythroid leukaemia-like morphology. Int J Lab Hematol. 2022. DOI:10.1111/ijlh.13911.

Reparaz P, Serrano I, Adan Pedroso R, Astigarraga I, de Pedro Olabarri J, Echebarria Barona A, et al. Clinical management of the acute complications of sickle cell anemia: 11 years of experience in a tertiary hospital. An Pediatr (Engl Ed). 2022. DOI:10.1016/j.anpede.2022.06.002.

Martinez Vazquez C, Lopez Rubio M, Del Orbe Barreto R. Southeast Asian ovalocytosis. Med Clin. 2022; 159(7): 347-348. DOI:10.1016/j.medcli.2022.03.025.

Roldan Galiacho V, Zaldumbide Duenas L, Lobo Olmedo A, Alonso Varela M, Garcia Ruiz JC. Intracytoplasmic crystalline inclusions in peripheral blood lymphocytes in small lymphocytic lymphoma. Br J Haematol. 2022; 199(1): 8-8. DOI:10.1111/bjh.18380.

Pascual Izquierdo MC, Mingot Castellano ME, Kerguelen Fuentes AE, Garcia Arroba Peinado J, Cid J, Jimenez M, et al. Real-world effectiveness of caplacizumab vs standard of care in immune thrombotic thrombocytopenic purpura. Blood Adv. 2022. DOI:10.1182/bloodadvances.2022008028.

Muniesa C, Gallardo F, Garcia Doval I, Estrach MT, Combalia A, Morillo Andujar M, et al. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry. J Eur Acad Dermatol Venereol. 2022. DOI:10.1111/jdv.18563.

Villalba A, Gonzalez Rodriguez AP, Arzuaga Mendez J, Puig N, Arnao M, Arguinano JM, et al. Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM). Leuk Lymphoma. 2022: 1-10. DOI:10.1080/10428194.2022.2123229.

Mateos Mazon M, Martinez Caballero CM, Mateos Mazon JJ, de Carlos Negro L, Del Otero Sanz L. [Observational study of the adherence to the correct use of face masks by the general population in open public places during two periods of the COVID-19 pandemic in four Spanish cities.]. Rev Esp Salud Publica. 2022; 96

Vilorio Marques L, Castanon Fernandez C, Mora E, Gutierrez L, Rey Bua B, Jimenez Lorenzo MJ, et al. Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD. Ther Adv Hematol. 2022; 13. DOI:10.1177/20406207221127547.

Orrantia A, Vazquez De Luis E, Astarloa Pando G, Terren I, Amarilla Irusta A, Polanco Alonso D, et al. Invivo expansion of a CD9+ decidual-like NK cell subset following autologous hematopoietic stem cell transplantation. iScience. 2022; 25(10): 105235-105235. DOI:10.1016/j.isci.2022.105235.

Roldan Galiacho V, Arana Berganza P, Amutio E, Garcia Ruiz JC. T-prolymphocytic leukaemia with sezary-like morphology. Int J Lab Hematol. 2022. DOI:10.1111/ijlh.13984.

Galiacho VR, Olmedo AL, Mendez JA, Garcia Ruiz JC. Various inclusions in chronic lymphocytic leukemia/small lymphocytic lymphoma. Blood Res. 2022. DOI:10.5045/br.2022.2022120.

Adan Pedroso R, De Pedro Olabarri J, Gonzalez Urdiales P, Moreno Diez M, Echebarria Barona A, Garcia Ariza M, et al. PATIENTS WITH RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH BLINATUMOMAB AND INOTUZUMAB. EXPERIENCE IN A TERTIARY CARE HOSPITAL. Pediatr Blood Cancer. 2022; 69: 574-574

Illarregi U, Bilbao Aldaiturriaga N, Jakjimovska A, Gutierrez Camino A, Del Orbe R, Astigarraga I, et al. NEW PROGNOSTIC BIOMARKERS IN ACUTE LYMPHOBLASTIC LEUKEMIA: LONG NON-CODING RNAS. Pediatr Blood Cancer. 2022; 69

Lobo Olmedo A, Arzuaga Mendez J, Balerdi A, Amutio E, Garcia Ruiz JC. Decreased glomerular filtration rate is related to increased mucositis in autologous stem cell transplantation conditioned with high dose melphalan. Bone Marrow Transplant. 2022; 57(SUPPL 1): 174-174

Arzuaga Mendez J, Lopez Santillan M, Garcia Ruiz JC, Lopez E, Martin Guerrero I. Systematic Review of the Potential of MicroRNAs in the Management of Patients with Follicular Lymphoma. Crit Rev Oncol Hematol. 2021; 159: 103247-103247. DOI:10.1016/j.critrevonc.2021.103247.

Arzuaga Mendez J, Moreno M, Mateos Mazon JJ, Vara M, Duenas M, Del Orbe RA et al. Acquired thrombotic thrombocytopenic Purpura diagnosed during first trimester of pregnancy with excellent outcome after plasma exchange and rituximab, a case report. Clin Case Rep. 2021; 9(3): 1304-1306. DOI:10.1002/ccr3.3752.

Rizzuto V, Koopmann TT, Blanco Alvarez A, Tazon Vega B, Idrizovic A, Diaz de Heredia C et al. Usefulness of NGS for Diagnosis of Dominant Beta-Thalassemia and Unstable Hemoglobinopathies in Five Clinical Cases. Front Physiol. 2021; 12: 628236-628236. DOI:10.3389/fphys.2021.628236.

García Azorín D, Abildúa M, Aguirre M, Fernández SF, Moncó JCG, Guijarro Castro C et al. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry. J Neurol Sci. 2021; 423: 117283-117283. DOI:10.1016/j.jns.2020.117283.

Lobo Olmedo A, Galiacho VR, Arzuaga Mendez J, Ancin I, Garcia Ruiz JC. Acute megakaryoblastic leukaemia with erythrophagocytosis. Br J Haematol. 2021; 194(4): 658-658. DOI:10.1111/bjh.17454.

Urrechaga E, Fernandez M, Orbe RD. Hb Johnstown is detected on Mindray BC 6800 Plus analyzer. Clin Chem Lab Med. 2021; 59(10): 386-388. DOI:10.1515/cclm-2021-0314.

Garcia Gutierrez CA, Cuetara Garcia MS, Moragues MD, Ligero J, Quevedo SM, Buitrago MJ. Low sensitivity of conventional fungal agars in fungemia by Rhodotorula mucilaginosa: description of two cases. Ann Clin Microbiol Antimicrob. 2021; 20(1). DOI:10.1186/s12941-021-00427-w.

Alvarez Roman MT, Benitez O, Canaro MI, Lopez Fernandez MF, Lopez Jaime FJ, Mateo Arranz J et al. Expert opinion paper on the treatment of hemophilia B with albutrepenonacog alfa. Expert Opin Biol Ther. 2021. DOI:10.1080/14712598.2021.1932811.

Bregon Villahoz M, Moragues M, Arrieta Aguirre I, Azkargorta M, Lainz L, Diez Zapirain M et al. Antibacterial and Antifungal Activity of the Human Endometrial Fluid during the Natural Cycle. Infectious Diseases in Obstetrics and Gynecology. 2021; 2021: 8849664-8849664. DOI:10.1155/2021/8849664.

Palanques Pastor T, Megias Vericat JE, Martinez P, Lopez Lorenzo JL, Cornago Navascues J, Rodriguez Macias G et al. Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group. Leuk Lymphoma. 2021; 62(12): 1-11. DOI:10.1080/10428194.2021.1948031.

Martin I, Villamon E, Abellan R, Calasanz MJ, Irigoyen A, Sanz G et al. Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations. Br J Haematol. 2021. DOI:10.1111/bjh.17675.

Lopez Santillan M, Lopez E, Alvarez Gonzalez P, Martinez G, Arzuaga Mendez J, Ruiz Diaz I et al. Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: A systematic review. Crit Rev Oncol Hematol. 2021; 165: 103430-103430. DOI:10.1016/j.critrevonc.2021.103430.

Morado M, Villegas AM, de la Iglesia S, Martinez Nieto J, Barreto RD, Beneitez D et al. Consensus document for the diagnosis and treatment of pyruvate kinase deficiency. Med Clin. 2021; 157(5). DOI:10.1016/j.medcli.2020.10.018.

Diez A, Carrano G, Bregon Villahoz M, Cuetara M, Garcia Ruiz JC, Fernandez Larrinoa I et al. Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients. Diagn Microbiol Infect Dis. 2021; 101(3). DOI:10.1016/j.diagmicrobio.2021.115509.

Roldan Galiacho V, Lobo Olmedo A, Aranguren Del Castillo L, Arzuaga Mendez J, Garcia Ruiz JC. Lymphocytes with auer rod-like inclusions in chronic lymphocytic leukemia. Hematology, Transfusion and Cell Therapy. 2021. DOI:10.1016/j.htct.2021.06.018.

Orrantia A, Terrén I, Astarloa Pando G, González C, Uranga A, Mateos Mazón JJ et al. NK Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation: Association Between NK Cell Maturation Stage and Outcome in Multiple Myeloma. Front Immunol. 2021; 12: 748207-748207. DOI:10.3389/fimmu.2021.748207.

Herrera L, Santos S, Vesga MA, Carrascosa T, Garcia Ruiz JC, Perez Martinez A et al. The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers. Cancers (Basel). 2021; 13(21). DOI:10.3390/cancers13215418.

Roldan GV, Arzuaga MJ, Aranguren DCL, Martin MX, De Pedro OJ, Garcia OS et al. WHAT IS BEHIND HEMOPHAGOCYTIC SYNDROME? EXPERIENCE OF A CENTER. Haematologica. 2021; 106(10): 286-287

Olabarri JD, Loureiro B, ASTIGARRAGA I, Guerra E, Echebarria Barona A, Adan R et al. Life-Threatening Complications at Diagnosis in Congenital Leukemia. Pediatr Blood Cancer. 2021; 68: 448-448

Olmedo L, Barreto R, Pampliega V, Del Castillo A, Varela A, Berganza A et al. GENOTYPE-PHENOTYPE CORRELATION IN HEREDITARY SPHEROCYTOSIS. Haematologica. 2021; 106(10): 109-110

Orrantia A, Terren I, Pando GA, Gonzalez C, Uranga A, Mazon JJM et al. High frequency of mature CD57+NKG2A-NK cells associate with poor disease progression after autologous hematopoietic stem cell transplantation in multiple myeloma patients. Eur J Immunol. 2021; 51: 271-271

Rodriguez Arboli E, Martinez Cuadron D, Rodriguez Veiga R, Carrillo Cruz E, Gil Cortes C, Serrano Lopez J et al. Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study. Transpl Cell Ther. 2021; 27(4). DOI:10.1016/j.jtct.2020.12.029.

Bogliolo M, Pujol R, Aza Carmona M, Muñoz Subirana N, Rodriguez Santiago B, Casado JA, et al. Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies. J Med Genet. 2020; 57(4): 258-268. DOI:10.1136/jmedgenet-2019-106249.

Castiella A, Urreta I, Zapata E, Zubiaurre L, Alústiza JM, Otazua P, et al. Liver iron concentration in dysmetabolic hyperferritinemia: Results from a prospective cohort of 276 patients. Ann Hepatol. 2020; 19(1): 31-35. DOI:10.1016/j.aohep.2019.07.014.

Azkargorta M, Bregón Villahoz M, Escobes I, Ibáñez Pérez J, Iloro I, Iglesias M, et al. In-depth proteomics and natural peptidomics analyses reveal antibacterial peptides in human endometrial fluid. J Proteomics. 2020; 216: 103652-103652. DOI:10.1016/j.jprot.2020.103652.

Fenaux P, Platzbecker U, Mufti GJ, Garcia Manero G, Buckstein R, Santini V, et al. Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes. N Engl J Med. 2020; 382(2): 140-151. DOI:10.1056/NEJMoa1908892.

Ramis Zaldivar JE, Gonzalez Farré B, Balagué O, Celis V, Nadeu F, Salmerón Villalobos J, et al. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. Blood. 2020; 135(4): 274-286. DOI:10.1182/blood.2019002699.

Gutiérrez Jomarrón I, López Rubio M, Morado Arias M, Arrizabalaga B, de la Iglesia S, Beneitez D, et al. Autoimmune haemolytic anaemias: A retrospective study of 93 patients. Med Clin. 2020; 154(9): 331-337. DOI:10.1016/j.medcli.2019.06.024.

Garcés JJ, Simicek M, Vicari M, Brozova L, Burgos L, Bezdekova R, et al. Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination. Leukemia. 2020; 34(2): 589-603. DOI:10.1038/s41375-019-0588-4.

Sánchez JMH, Lumbreras E, Díez Campelo M, González T, López DA, Abáigar M, et al. Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients. Pharmacogenomics J. 2020; 20(5): 664-671. DOI:10.1038/s41397-020-0154-5.

Sancho JM, Navarro B, Soler Campos JA, Pérez de Oteyza J, de Barrenetxea Lekue C, Bregni M, et al. Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas. Eur J Haematol. 2020; 104(5): 499-508. DOI:10.1111/ejh.13392.

Tamayo Orbegozo E, Amo L, Díez García J, Amutio E, Riñón M, Alonso M, et al. Emerging Role of Podocalyxin in the Progression of Mature B-Cell Non-Hodgkin Lymphoma. Cancers (Basel). 2020; 12(2). DOI:10.3390/cancers12020396.

Ferrer Marín F, Arroyo AB, Bellosillo B, Cuenca EJ, Zamora L, Hernández Rivas JM, et al. miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk. Leukemia. 2020; 34(10): 2648-2659. DOI:10.1038/s41375-020-0767-3.

Garces JJ, Bretones G, Burgos L, Valdes Mas R, Puig N, Cedena MT, et al. Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma. Leukemia. 2020; 34(11): 3007-3018. DOI:10.1038/s41375-020-0883-0.

Sobas M, Talarn Forcadell MC, Martinez Cuadron D, Escoda L, Garcia Perez MJ, Mariz J, et al. PLZF-RARalpha, NPM1-RARalpha, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review. Cancers (Basel). 2020; 12(5). DOI:10.3390/cancers12051313.

Orrantia A, Terrén I, Izquierdo Lafuente A, Alonso Cabrera JA, Sandá V, Vitallé J, et al. A NKp80-Based Identification Strategy Reveals that CD56 neg NK Cells Are Not Completely Dysfunctional in Health and Disease. iScience. 2020; 23(7): 101298-101298. DOI:10.1016/j.isci.2020.101298.

Martínez López J, Mateos MV, Encinas C, Sureda A, Hernández Rivas JÁ, Lopez de la Guía A, et al. Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality. Blood Cancer J. 2020; 10(10): 103-103. DOI:10.1038/s41408-020-00372-5.

Martinez Cuadron D, Serrano J, Gil C, Tormo M, Martinez Sanchez P, Perez Simon JA, et al. Evolving treatment patterns and outcomes in older patients (=60 years) with AML: changing everything to change nothing?. Leukemia. 2020. DOI:10.1038/s41375-020-01058-4.

Larrea E, Fernandez Mercado M, Guerra Assuncao JA, Wang J, Goicoechea I, Gaafar A, et al. Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma. Int J Mol Sci. 2020; 21(22). DOI:10.3390/ijms21228795.

Muntañola A, Villacampa G, Hernández Rivas JÁ, Alonso R, Mirás F, Osorio S, et al. Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country. Exp Hematol Oncol. 2020; 9(1): 37-37. DOI:10.1186/s40164-020-00195-x.

Posada Alcon L, Diez Zubia H, Martin Martitegui X, Amutio Diez ME, Garcia Ruiz JC. Risk Factors for Intensive Care Unit Admission in Patients with Non-hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation. Bone Marrow Transplant. 2020; 55(SUPPL 1): 520-521

Martin I, Villamon E, Abellan R, Calasanz MJ, Irigoyen A, Sanz GF, et al. Myelodysplastic Syndromes with 20q Deletion: Incidence, Prognostic Value and Impact on Response to Azacitidine of ASXL1 Chromosomal Deletion and Genetic Mutations. Blood. 2020; 136. DOI:10.1182/blood-2020-139588.

Cadenas FL, Lumbreras E, Xicoy B, Sanchez J, Coll R, Slama B, et al. Phase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent (TD) Low Risk Del(5q) MDS Patients - Interim Analysis of the European Sintra-REV Trial. Blood. 2020; 136. DOI:10.1182/blood-2020-140339.

Rueda J, Perez CG, Rodriguez CV, Vallejo TC, Garaizabal BS, Ealo M, et al. Validation of the Response Speed Rule to Predict the Efficacy of a Therapeutic Regimen in Myeloma. Blood. 2020; 136. DOI:10.1182/blood-2020-138555.

Garcia Gutierrez V, Milojkovic D, Hernandez Boluda JC, Claudiani S, Mateos MLM, Casado Montero L, et al. Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients. Ann Hematol. 2019; 98(2): 321-330. DOI:10.1007/s00277-018-3507-2.

Mingo J, Luna S, Gaafar A, Nunes Xavier CE, Torices L, Mosteiro L, et al. Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology. NPJ Precis Oncol. 2019; 3: 11-11. DOI:10.1038/s41698-019-0083-4.

Arzuaga Mendez J, Prieto Fernandeza E, Lopez E, Martin Guerrero I, Carlos Garcia Ruiz J, Garcia Orad A. Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review. Crit Rev Oncol Hematol. 2019; 139: 7-15. DOI:10.1016/j.critrevonc.2019.04.013.

Elliott C, Carrascosa T, Souchet J-L, Smith D, Malaxetxebarria I, You J, et al. Multicentre evaluation of Erytra Eflexis (R), a benchtop fully automated analyser with a compact design for routine use in blood transfusion laboratory. Transfus Med. 2019; 29(6): 401-407. DOI:10.1111/tme.12619.

Codina M, Ramirez Escudero G, Garcia Ibarrondo N, Manzanal Rey A, Bravo Martinez I, Aurrekoetxea Bajeneta G, et al. Heart failure and tachycardiomyopathy in a patient taking ibrutinib: a novel tyrosine kinase inhibitor. Eur J Heart Fail. 2019; 21: 303-303

Prieto Molano MB, Bregon M, Moragues D, Azkargorta M, Diez Zapirain M, Iglesias M, et al. Antibacterial and antifungal activity of the human endometrial fluid during the natural cycle. Hum Reprod. 2019; 34(1): 289-289

Jose Garces J, Bretones G, Burgos L, Valdes Mas R, Alignani D, Alvarez Puente D, et al. Circulating Tumor Cells (CTCs) for Comprehensive and Multiregional Non-Invasive Genetic Characterization of Multiple Myeloma (MM). Clin Lymphoma Myeloma Leuk. 2019; 19: 351-351. DOI:10.1016/j.clml.2019.09.580.

Chen Liang TH, Hurtado AM, Zurdo M, Such E, Palomo L, Jimenez Lorenzo MJ, et al. GERM PREDISPOSITION IN MYELODYSPLASTIC SYNDROMES IN YOUNG ADULTS WITHOUT PREVIOUS ORGANIC DYSFUNCTION: NEW FINDING OF DELETERIOUS VARIANTS IN GENES RESPONSIBLE FOR MICROSATELLITE INSTABILITY. Haematologica. 2019; 104(3): 1-2

Cespedes Lopez R, Del Orbe Barreto RA, Arrizabalaga Amuchastegi B, Maruri Machado N, Insunza Oleaga L, Moereno Gamiz M, et al. IS CYTOMETRY USEFUL FLOW IN THE DIAGNOSIS OF HEREDITARY SPHEROCYTOSIS?. Haematologica. 2019; 104(3): 178-178

Caballero Alvarez D, Arrizabalaga Amuchastegui B, Urquia Plazaola A, Perez de Nanclares G, Otero Longo I, Moreno Gamiz M, et al. FALSE ALARM!. Haematologica. 2019; 104(3): 179-179

Cespedes Lopez R, Insunza Oleaga L, Moreno Gamiz M, Arzuaga Mendez J, Barreto Rafael DOA, Arrizabalaga Amuchastegi B, et al. LEFT ISOMERISM AND ERYTHROCYTE MORPHOLOGY. Haematologica. 2019; 104(3): 257-257

Arzuaga Mendez J, Lopez Santillan M, Lopez E, Martin Guerrero I, Amutio Diez E, Garcia Orad A, et al. CLASSIC EVOLUTION OF THE DIFFUSED BIG CELL LYMPHOMA (LDCGB) THROUGH NEXT GENERATION SEQUENCING (NGS), THROUGH THREE CASES. Haematologica. 2019; 104(3): 373-374

Arzuaga Mendez J, Moreno Gamiz M, Carlos Garcia J. Similar survival trends in transformed follicular lymphoma and DLBCL after ASCT. Single center cohort with a long follow-up. Bone Marrow Transplant. 2019; 54(1): 471-472

Barrenetxea Lekue C, Grasso Cicala S, Leppa S, Larsen TS, Herraez Rodriguez S, Alonso Caballero C, et al. Pixantrone beyond monotherapy: a review. Ann Hematol. 2019; 98(9): 2025-2033. DOI:10.1007/s00277-019-03749-0.

Casado LF, Garcia Ormena N, Perez Encinas M, Ferrer F, Sagues M, Garcia Gutierrez V, et al. PRELIMINARY RESULTS OF THE RELMC-NOVA STUDY: KINETICS OF THE MOLECULAR RESPONSE IN PATIENTS RECEIVE DIAGNOSTICS OF LMC-FC TREATED WITH ITKS IN 1 LINE. Haematologica. 2019; 104(3): 170-171

Roldan Galiacho V, Gaafar Eleraky A, Landeta Callejo E, Arzuaga Mendez J, Moreno Gamiz M, Sierra Aisa C, et al. ANATOMO-CYTOLOGICAL DIFFERENCES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA JAK2, CALR, MPL AND TRIPLE NEGATIVES. Haematologica. 2019; 104(3): 306-306

Barrenechea Lekue C, Alaez Uson C, Herraez Rodriguez S, Romero Dominguez S, Hernandez Vazquez L, Alonso Caballero C, et al. PREBEN, PIXANTRONE, RITUXIMAB, ETOPOSIDE AND BENDAMUSTINE, AS A RESCUE TREATMENT OF AGGRESSIVE LYMPHOMES. Haematologica. 2019; 104(3): 375-375

Pulido R, Mingo J, Gaafar A, Nunes Xavier CE, Luna S, Torices L, et al. Precise Immunodetection of PTEN Protein in Human Neoplasia. Cold Spring Harb Perspect Med. 2019; 9(12). DOI:10.1101/cshperspect.a036293.

Herrera L, Santos S, Vesga MA, Anguita J, Martin Ruiz I, Carrascosa T, et al. Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against cd19 positive leukemic cells. Hum Gene Ther. 2019; 30(11): 59-59

Herrera L, Santos S, Vesga MA, Anguita J, Martin Ruiz I, Carrascosa T, et al. ADULT PERIPHERAL BLOOD AND UMBILICAL CORD BLOOD NK CELLS ARE GOOD SOURCES FOR EFFECTIVE CAR THERAPY AGAINST CD19 POSITIVE LEUKEMIC CELLS. Hum Gene Ther. 2019; 30(12): 18-18

Herrera L, Santos S, Vesga MA, Anguita J, Martin Ruiz I, Carrascosa T, et al. Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells. Sci Rep. 2019; 9(1): 18729-18729. DOI:10.1038/s41598-019-55239-y.

Carrano G, Paulone S, Lainz L, Sevilla M, Blasi E, Moragues M. Anti-Candida albicans germ tube antibodies reduce in vitro growth and biofilm formation of C. albicans. Rev Iberoam Micol. 2019; 36(1): 9-16. DOI:10.1016/j.riam.2018.07.005.

Puente M, Fariñas Alvarez C, Moreto A, Sánchez Velasco P, Ocejo Vinyals JG, Fariñas MC, et al. Low pre-transplant levels of mannose-binding lectin are associated with viral infections and mortality after haematopoietic allogeneic stem cell transplantation. BMC IMMUNOL. 2019; 20(1): 40-40. DOI:10.1186/s12865-019-0318-8.

Peñalver FJ, Márquez JA, Durán S, Giraldo P, Martín A, Montalbán C, et al. Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial. Cancer Med. 2019; 8(16): 6955-6966. DOI:10.1002/cam4.2555.

Moreno Carralero M, Arrizabalaga Amuchastegui B, Sanchez Guilarte J, Morado Arias M, Velasco Valdazo A, de Inigo S, et al. Missense variants in ALAS2 gene in five patients. Int J Lab Hematol. 2019; 41(1): 5-9. DOI:10.1111/ijlh.12902.

Arrieta Aguirre I, Menéndez Manjón P, Cuétara MS, Fernández de Larrinoa I, García Ruiz JC, Moragues MD. Sequencing of FKS Hot Spot 1 from Saprochaete capitata To Search for a Relationship to Reduced Echinocandin Susceptibility. Antimicrob Agents Chemother. 2018; 62(2). DOI:10.1128/AAC.01246-17.

Aldamiz Echevarria L, Couce ML, Villate O, Fernandez Marmiesse A, Pinan MA. New CTSA mutation in early infantile galactosialidosis. Pediatr Int. 2018; 60(8): 761-762. DOI:10.1111/ped.13604.

Mingo J, Luna S, Gaafar A, Ruiz R, Carracedo A, Guerra I, et al. The relevance of precision epitope mapping for accurate oncologic diagnostic based on PTEN protein expression in tumours. Virchows Arch. 2018; 473(1): 138-138

Mendez JA, Juez NR, Martinez IL, Oleaga LI, Gamiz MM, Barreto RD, et al. IDIOPATHIC ERYTHROCYTOSIS, A BENIGN SITUATION?. Haematologica. 2018; 103(2): 99-99

Gamiz MM, Amuchastegui BA, Barreto R, Perez CG, Usategui MD, Mazon JJM, et al. THROMBOCITOPENIC THROMBOTIC PURPLE ACQUIRED IN THE FIRST QUARTER OF PREGNANCY: A PURPOSE OF A CASE. Haematologica. 2018; 103(2): 163-163

Caballero CA, Amuchastegui BA, Barreto RD, Martinez IL, Alvarez DC, Elguezabal JU, et al. UTILITY OF NGS IN THE DIAGNOSIS OF CONGENITAL HEMOLYTIC ANEMIAS OF APPEARANCE IN THE NEONATAL PERIOD. Haematologica. 2018; 103(2): 168-169

Gamiz MM, Mazon JJM, Alcon LP, Perez CG, Mendez JA, Martitegui XM, et al. CONDITIONING WITH BUMEL IN PATIENTS SUBJECTED TO DOUBLE AUTOMOTIVE TRANSPLANTATION IN MULTIPLE MYELOMA; EXPERIENCE OF A CENTER. Haematologica. 2018; 103(2): 260-261

Martinez Cuadron D, Montesinos P, Vellenga E, Bernal T, Salamero O, Holowiecka A, et al. Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy. Leukemia. 2018; 32(1): 21-29. DOI:10.1038/leu.2017.178.

Zaldumbide L, Caamano V, Camin MS, Malaxetxebarria S, Velasco V, Solano JD, et al. Malignant ossifying fibromyxoid tumour with multiple recurrences in a child. Virchows Arch. 2018; 473(1): 154-154

Camin MS, Mosteiro L, Velasco V, Malaxetxebarria S, Caamano V, Gonzalez M, et al. Solitary fibrous tumour of the pleura: review of cases in a university hospital over the last twenty years. Virchows Arch. 2018; 473(1): 325-325

Benito VV, Ramon LD, Borque AB, Terradillos SE, Marcos A, Camin MS, et al. Multinucleated giant cell angiohistiocitoma, a subtle pattern easy to miss. Virchows Arch. 2018; 473(1): 224-224

Benito VV, Hermosa MRG, Merino LP, Borque AB, Alvarez LA, de Larrinoa AF, et al. Papular epidermal nevus with "skyline" basal cell layer (PENS), and PEN syndrome in triplets siblings. Virchows Arch. 2018; 473(1): 88-89

Chen Liang TH, Lopez A, Palomo L, Del Castillo TB, Tormo M, Hermosin ML, et al. Germline and Acquired Genetic Variants in Myelodysplastic Syndromes in Young Adults without a Preexisting Disorder or Organ Dysfunction. Blood. 2018; 132. DOI:10.1182/blood-2018-99-116045.

Ramis Zaldivar JE, Gonzalez Farre B, Olga B, Celis V, Nadeu F, Andres M, et al. Large B-Cell Lymphomas in Pediatric and Young Adults Display Clinically Relevant Molecular Features Distinguishable from Adult Counterparts. Blood. 2018; 132(1). DOI:10.1182/blood-2018-99-114493.

Cadenas FL, Lumbreras E, Xicoy B, Sanchez Garcia J, Fenaux P, Coll R, et al. Phase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent (TD) Low Risk Del(5q) - Preliminary Blinded Analysis of the European Sintra-REV Trial. Blood. 2018; 132(1). DOI:10.1182/blood-2018-99-119430.

Roy N, Proven M, Roberts I, Tamary H, Swinkels DW, Patricia AM, et al. Towards an External Quality Assessment for Next Generation Sequencing in the Diagnosis of Rare Inherited Anaemias. Blood. 2018; 132. DOI:10.1182/blood-2018-99-111609.

Fenaux P, Platzbecker U, Mufti GJ, Garcia Manero G, Buckstein R, Santini V, et al. The Medalist Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions. Blood. 2018; 132. DOI:10.1182/blood-2018-99-110805.

Marin FF, Arroyo A, Bellosillo B, Zamora L, Fuentes AK, Velez P, et al. rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling. Blood. 2018; 132. DOI:10.1182/blood-2018-99-119221.

Caamano M, Lozano JJG, Ageda CA, Mazon JJM, Roca JR, Chulilla J, et al. HEMATOPOYETIC IMPLANT OF A SERIES OF PATIENTS MOBILIZED WITH PLERIXAFOR. MULTICENTER RETROSPECTIVE STUDY. Haematologica. 2018; 103: 244-244

Andres L, Velasco V, Saiz M, Mosteiro L, Caamano V, Malaxetxebarria S, et al. Primary diffuse large B-cell lymphoma of the breast: report of 8 cases. Virchows Arch. 2018; 473: 200-200

Espinet B, Ramos S, Gomez Llonin A, Bougeon S, Calasanz MJ, Blanco L, et al. Identification of Complex Karyotypes in Chronic Lymphocytic Leukemia: Comparison of Chromosome Banding Analysis and Genomic Microarray Techniques. Mod Pathol. 2018; 31: 514-514

Espinet B, Ramos S, Gomez Llonin A, Bougeon S, Calasanz MJ, Blanco L, et al. Identification of Complex Karyotypes in Chronic Lymphocytic Leukemia: Comparison of Chromosome Banding Analysis and Genomic Microarray Techniques. Lab Invest. 2018; 98: 514-514

DEL ORBE BARRETO RA. Hemolisis in diabetic patient. A case report. REV ESP ENDOCRINOL PEDIATR. 2018. DOI:10.3266.

García Noblejas A, Cannata Ortiz J, Conde E, González Barca E, Gutiérrez N, Rojas R, et al. Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO). Ann Hematol. 2017; 96(8): 1323-1330. DOI:10.1007/s00277-017-2998-6.

Villegas A, Núñez R, Gaya A, Cuevas Ruiz MV, Bosch JM, Carral A, et al. Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry. Ann Hematol. 2017; 96(10): 1727-1733. DOI:10.1007/s00277-017-3059-x.

Loo SK, ES CH'NG, Lawrie CH, Muruzabal MA, Gaafar A, Pomposo MP, et al. DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas. Pathology. 2017; 49(7): 731-739. DOI:10.1016/j.pathol.2017.08.009.

Ivars D, Teresa Orero M, Javier K, Diaz Vico L, Luis Garcia Gimenez J, Mena S, et al. Oxidative imbalance in low/intermediate-1-risk myelodysplastic syndrome patients: The influence of iron overload. Clin Biochem. 2017; 50(16-17): 911-917. DOI:10.1016/j.clinbiochem.2017.05.018.

Diez A, Carrano G, Cuetara MS, Garcia Ruiz JC, de Larrinoa IF, Moragues MD. Biomarkers for the diagnosis of Invasive Candidiasis. Mycoses. 2017; 60: 118-119

Arrieta Aguirre I, Menendez Manjon P, Cuetara MS, Lopez Soria L, Garcia Ruiz JC, Moragues MD. Molecular Identification of Saprochaete capitata in Human Blood and Paraffinized Tissue Samples. J Clin Microbiol. 2017; 55(8): 2556-2559. DOI:10.1128/JCM.00876-17.

Alonso Dominguez JM, Casado LF, Anguita E, Gomez Casares MT, Buno I, Ferrer Marin F, et al. PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase. PLoS One. 2017; 12(7). DOI:10.1371/journal.pone.0181366.

Irigoyen M, Garcia Ruiz JC, Berra E. The hypoxia signalling pathway in haematological malignancies. Oncotarget. 2017; 8(22): 36832-36844. DOI:10.18632/oncotarget.15981.

Ropero P, Erquiaga S, Arrizabalaga B, Perez G, de la Iglesia S, Torrejon MJ, et al. Phenotype of mutations in the promoter region of the beta-globin gene. J Clin Pathol. 2017; 70(10): 874-878. DOI:10.1136/jclinpath-2017-204378.

De La Iglesia S, McDonell CN, Valls AG, Romero MTC, Roncero M, Amunchastegui BA, et al. SURGICAL MANAGEMENT OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) - DATA FROM THE SPANISH PNH REGISTRY. Haematologica. 2017; 102(2): 403-404

Cadenas FL, Xicoy B, Bargay J, Sanz G, Amigo ML, Arrizabalaga B, et al. PRELIMINARY ANALYSIS OF EFFICACY AND SAFETY OF SINTRA-REV CLINICAL TRIAL, LENALIDOMIDE VS PLACEBO PHASE 3 STUDY IN LOW/INT-1 MDS PATIENTS WITH DEL(5Q) AND TRANSFUSION INDEPENDENCY. Haematologica. 2017; 102(2): 484-485

De La Iglesia S, Morado M, Arrizabalaga B, Gonzalez A, Beneitez D, Rubio ML, et al. PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND APLASTIC ANAEMIA - DATA FROM THE SPANISH PNH REGISTRY. Haematologica. 2017; 102(2): 705-705

Colado E, Arias MM, Valls AG, Rubio ML, Amuchastegui BA, Rubira EL, et al. CLINICAL IMPACT OF AGE AND COMORBIDITY IN PNH PATIENTS. Haematologica. 2017; 102(2): 706-706

Puiggros A, Gomez Llonin A, Ramos S, Calasanz MJ, Blanco L, Collado R, et al. COMPARISON OF CHROMOSOME BANDING ANALYSIS AND GENOMIC MICROARRAY TECHNIQUES FOR THE DETECTION OF COMPLEX KARYOTYPES IN CHRONIC LYMPHOCYTIC LEUKEMIA. Haematologica. 2017; 102(2): 422-422

Calvo X, Arenillas L, Luno E, Senent L, Arnan M, Ramos F, et al. Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R). Am J Hematol. 2017; 92(7): 614-621. DOI:10.1002/ajh.24732.

Baptista MJ, Granada I, Morgades M, Calasanz MJ, Canals J, De Castro DR, et al. Monosomal karyotype in chronic lymphocytic leukemia: Association with clinical and biological features and potential prognostic significance. Am J Hematol. 2017; 92(7): 132-135. DOI:10.1002/ajh.24754.

Puiggros A, Collado R, Calasanz MJ, Ortega M, Ruiz Xiville N, Rivas Delgado A, et al. Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions. Oncotarget. 2017; 8(33): 54297-54303. DOI:10.18632/oncotarget.17350.

Arrieta Aguirre I, Menendez Manjon P, de Larrinoa IF, Moragues MD. Experimental evolution of Candida Albicans in the presence of increasing concentrations of fluconazole. Mycoses. 2017; 60: 73-74

Tamayo Orbegozo E, Amo L, Riñón M, Nieto N, Amutio E, Maruri N, et al. Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells. Oncotarget. 2017; 8(59): 99722-99739. DOI:10.18632/oncotarget.21283.

Nomdedeu M, Pereira A, Calvo X, Colomer J, Sole F, Arias A, et al. Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group. Leuk Res. 2017; 63: 85-89. DOI:10.1016/j.leukres.2017.10.011.

Blanco Vidal MJ, Duenas Usategui M, Balerdi Malcorra A, Puente Pomposo M, Garcia Ruiz JC, Montejo Baranda JM. Piomyositis due to Escherichia coli in haematological patients, an increasing pathology. Rev Esp Quimioter. 2017; 30(3): 231-233

Arenillas L, Calvo X, Luno E, Senent L, Arnan M, Ramos F, et al. THE PROGNOSTIC EVALUATION OF MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS CAN BE IMPROVED BY CONSIDERING BONE MARROW BLASTS FROM NONERYTHROID CELLS. Leuk Res. 2017; 55(1): 135-136. DOI:10.1016/S0145-2126(17)30348-X.

Calvo X, Arenillas L, Luno E, Senent L, Arnan M, Ramos F, et al. CALCULATING IPSS-R BY ENUMERATING BONE MARROW BLASTS FROM NONERYTHROID CELLULARITY IMPROVES OUTCOME PREDICTION IN MDS WITH ERYTHROID PREDOMINANCE. Leuk Res. 2017; 55(1): 137-138. DOI:10.1016/S0145-2126(17)30351-X.

Costa D, Nomdedeu M, Pereira A, Calvo X, Colomer J, Soler F, et al. CLINICAL AND BIOLOGICAL SIGNIFICANCE OF Y CHROMOSOME LOSS IN A SERIES OF 2,423 MALE PATIENTS WITH MDS AND CMML. Leuk Res. 2017; 55(1): 122-123. DOI:10.1016/S0145-2126(17)30321-1.

Cadenas FL, Xicoy B, Sanchez J, Fenaux P, Rivas J, Amigo ML, et al. SINTRA-REV CLINICAL TRIAL: PRELIMINARY ANALYSIS OF EFFICACY AND SAFETY AT WEEK 12 OF TREATMENT IN MDS DEL(5Q) AND TRANSFUSION INDEPENDENCE. Leuk Res. 2017; 55(1): 52-52

Senent L, Lorenzo I, Vicente A, Alonso E, Sanzo C, Ramos F, et al. PROGNOSTIC IMPLICATION OF THE PERCENTAGE OF ERYTHROID CELLS IN BONE MARROWAT DIAGNOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME. Leuk Res. 2017; 55(1): 151-152. DOI:10.1016/S0145-2126(17)30375-2.

Puiggros A, Gomez Llonin A, Ramos S, Calasanz MJ, Blanco L, Pinan MA, et al. Comparison of chromosome banding analysis and genomic microarray techniques for the detection of complex karyotypes in chronic lymphocytic leukemia. Leuk Lymphoma. 2017; 58(1): 205-206

Arzuaga J, Mateos J, Lopez Soria L, Amutio E, Garcia Ruiz JC. Blood culture number is related to microbiological documentation rate of febrile episodes in patients undergoing autologous stem cell transplantation: single-centre experience in 66 consecutive procedures. Bone Marrow Transplant. 2017; 52(1): 242-242

Perez CG, Malcorra AB, Alcon LP, Callejo EL, Martitegui XM, Diez EA, et al. Association between grade of response and outcomes in transplant-eligible myeloma patients. Bone Marrow Transplant. 2017; 52(1): 458-458

Mazon JJM, Diez M, Iruin AU, Malcorra AB, Verde F, Ruiz JCG. When is the best moment, and which is the best conditioning regimen to use, for the second autologous transplantation in multiple myeloma patients?. Bone Marrow Transplant. 2017; 52(1): 474-475

Carrano G, Arrieta I, Sevilla MJ, Moragues MD. Identification of Candida albicans antigens reacting with anti-germ tube antibodies from a rabbit model of Invasive Candidiasis. Phage display approach. Mycoses. 2017; 60: 195-196

MORAGUES TOSANTOS MD. Diagnóstico de la candidiasis invasiva mediante biomarcadores: hyphal wall protein-1 y metionina sintasa. Rev Iberoam Micol. 2017; 34(3): 7-19

Ramirez Garcia A, Rementeria A, Aguirre Urizar JM, Moragues MD, Antoran A, Pellon A, et al. Candida albicans and cancer: Can this yeast induce cancer development or progression?. Crit Rev Microbiol. 2016; 42(2): 181-193. DOI:10.3109/1040841X.2014.913004.

Del Orbe Barreto R, Arrizabalaga B, De la Hoz Rastrollo AB, Garcia Orad A, Gonzalez Vallejo I, Bento C, et al. Hereditary xerocytosis, a misleading anemia. Ann Hematol. 2016; 95(9): 1545-1546. DOI:10.1007/s00277-016-2716-9.

Puiggros A, Collado R, Calasanz MJ, Ortega M, Ruiz Xiville N, Rivas Delgado A, et al. PATIENTS WITH COMPLEX KARYOTYPE (CK) LACKING TP53 DELETIONS SHOW AN EQUIVALENT DISMAL CLINICAL OUTCOME AS THOSE WITH TP53 DELETIONS AND NON-CK IN CHRONIC LYMPHOCYTIC LEUKEMIA. Haematologica. 2016; 101(1): 57-57

Vara M, Puente M, Amutio E, Balerdi A, Olazabal I, Diez H, et al. ANALYSIS OF RISK FACTORS FOR CENTRAL NERVOUS SYSTEM RELAPSE IN DIFFUSE LARGE B-CELL LYMPHOMA: THE EXPERIENCE OF A TERTIARY HOSPITAL. Haematologica. 2016; 101(1): 704-704

Del Orbe Barreto R, Arrizabalaga B, Martin Martitegui X, Erquiaga S, Garcia Ruiz JC. CHELATION THERAPY IN NON-TRANSFUSION-DEPENDENT IRON LOADING ANEMIA. EXPERIENCE IN A TERTIARY HOSPITAL. Haematologica. 2016; 101(1): 852-852

Del Orbe Barreto R, Arrizabalaga B, de la Hoz AB, Araguees P, Garcia Ruiz JC, Arrieta A, et al. Severe neonatal jaundice due to a de novo glucose-6-phosphate dehydrogenase deficient mutation. Int J Lab Hematol. 2016; 38(2): 27-29. DOI:10.1111/ijlh.12455.

Martinez Cuadron D, Montesinos P, Ossenkoppele G, Gonzalez Huerta AJ, Salamero O, Holowiecka A, et al. LONG-TERM OUTCOME OF ELDERLY PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ANTHRACYCLINE MONOTHERAPY AND ATRA-BASED PETHEMA PROTOCOLS. Haematologica. 2016; 101(1): 178-178

Blanco G, Puiggros A, Baliakas P, Athanasiadou A, Garcia Malo MD, Collado R, et al. CHROMOSOME 8 ABNORMALITIES ARE ASSOCIATED WITH AN EVEN WORSE OUTCOME AND KARYOTYPE COMPLEXITY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND TP53 ABERRATIONS. Haematologica. 2016; 101(1): 229-230

Villegas A, Arrizabalaga B, Bonanad S, Colado E, Gaya A, Gonzalez A, et al. Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria. Med Clin. 2016; 146(6): 278-278. DOI:10.1016/j.medcli.2015.12.012.

Balerdi A, Diez H, Iglesias AM, Elicegui ML, Olazabal I, Vara M, et al. Autologous-SCT In Mantle Cell Lymphoma: Role Of Short Induction And Conditioning Regimen In A Series Of Patients With Long Term Follow Up. Bone Marrow Transplant. 2016; 51(1): 297-297

Martinez Feito A, Melero J, Mora Diaz S, Rodriguez Vigil C, Elduayen R, Gonzalez Granado LI, et al. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation. Immunobiology. 2016; 221(1): 40-47. DOI:10.1016/j.imbio.2015.08.004.

Arenillas L, Calvo X, Luno E, Senent L, Alonso E, Ramos F, et al. Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes. J Clin Oncol. 2016; 34(27): 3284-3284. DOI:10.1200/JCO.2016.66.9705.

Del Orbe Barreto R, Arrizabalaga B, De la Hoz AB, García Orad Á, Tejada MI, Garcia Ruiz JC, et al. Detection of new pathogenic mutations in patients with congenital haemolytic anaemia using next-generation sequencing. Int J Lab Hematol. 2016; 38(6): 629-638. DOI:10.1111/ijlh.12551.

Calvo X, Arenillas L, Luño E, Senent L, Arnan M, Ramos F, et al. Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes. Mod Pathol. 2016; 29(12): 1541-1551. DOI:10.1038/modpathol.2016.146.

Martitegui Xabier M, Amuchastegui Beatriz A, Cheong Anthony PL, Gradilla Paloma R, Telleria Sara E, Barreto Rafael DO, et al. MYELODYSPLASTIC SYNDROME WITH ALPHA THALASSEMIA ACQUIRED BY MUTATION OF ATRX GENE: ABOUT A CASE. Haematologica. 2016; 101(4): 150-151

Barreto Rafael DO, Beatriz A, Ana Belen DH, Martitegui Xabier M, Africa G, Javier M, et al. IDENTIFICATION OF TWO NEW MUTATIONS IN THE GENE OF THE ANCHIRINE CAUSES OF HEREDITARY SPHEROCYTOSIS. Haematologica. 2016; 101(4): 260-260

Jomarron Isabel G, Marta M, Beatriz A, Silvia DI, David B, Ines V, et al. RITUXIMAB IN AUTOMATIC HEMOLITICAL ANEMIA. RESULTS OF THE NATIONAL REGISTRY OF AUTOIMMUNE HEMOLYTIC ANEMIA. SPANISH GROUP OF ERITROPATOLOGY. Haematologica. 2016; 101(4): 53-53

Bordes Dolors C, Saavedra Arturo P, del Castillo Teresa B, Fernandez Elisa L, Boix Santiago B, Santillana Guillermo S, et al. STUDY OF CLINICAL CHARACTERISTICS AND PROGNOSIS OF MYELODYSPLASTIC SYNDROMES WITH ISOLATED Y CHROMOSOME DELAY. Haematologica. 2016; 101(4): 145-145

Felix L, Blanca X, Elisa L, Monica C, Carme P, Marisa C, et al. CLINICAL AND BIOLOGICAL FACTORS RELATED TO THE TRANSFUSIONAL DEPENDANCE IN SMD DIAGNOSED PATIENTS (5Q) AND TRANSFUSIONAL INDEPENDENCE TO DIAGNOSIS. Haematologica. 2016; 101(4): 65-66

Alcon Laura P, Malcorra Amaia B, Perez Clara G, Martitegui Xabier M, Callejo Elena L, Pampliega Miriam V, et al. IMPACT OF BORTEZOMIB'S ACCUMULATED DOSES IN THE SURVIVAL OF PATIENT CANDIDATES TO AUTOLOGOUS TRANSPLANTATION: EXPERIENCE OF A CENTRE. Haematologica. 2016; 101(4): 99-100

Maria Angeles PF, Idoya Maria AA, Callejo Elena L, Amuchastegui Beatriz A, Quintana Ana M, Aisa Cristina S, et al. ASSESSMENT OF THE RESULTS OF THE MUTATIONS STUDY IN PATIENTS WITH SUSPECTED PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE SYNDROMES. Haematologica. 2016; 101(4): 185-185

Varela Enrique C, Arias Marta M, Valls Anna G, Rubio Montserrat L, Amuchastegui Beatriz A, Rubira Esperanza L, et al. IMPORTANCE OF AGE AND COMORBILITY IN PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA. Haematologica. 2016; 101(4): 262-263

Silvia DI, Marta M, Beatriz A, Ataulfo G, David B, Rubio Montserrat L, et al. HPN-APLASIA. EXPERIENCE OF THE HPN SPANISH REGISTRY. Haematologica. 2016; 101(4): 263-263

Zapata E, Castiella A, Urreta I, Alustiza JM, Salvador E, Otazua P, et al. DIAGNOSTIC ALGORITHM FOR HIGH LIVER IRON OVERLOAD: RESULTS FROM A PROSPECTIVE STUDY OF 312 PATIENTS WITH HYPERFERRITINEMIA. J Hepatol. 2016; 64(2): 296-296. DOI:10.1016/S0168-8278(16)00375-5.

Astigarraga I, Garcia Obregon S, Agirrebengoa K, Balerdi A, Carlos Garcia Ruiz J, Diaz B, et al. HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS COMPLICATING ADULT PATIENTS WITH HIV INFECTION. Pediatr Blood Cancer. 2015; 62(1): 2-2

Saumell S, Sole F, Arenillas L, Montoro J, Valcarcel D, Pedro C, et al. Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?. PLoS One. 2015; 10(6). DOI:10.1371/journal.pone.0129375.

Tapia G, Baptista M, Munoz Marmol A, Gaafar A, Puente Pomposo M, Garcia O, et al. MYC protein expression is associated with poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system. APMIS. 2015; 123(7): 596-603. DOI:10.1111/apm.12390.

Remacha AF, Arrizabalaga B, Villegas A, Soledad Duran M, Hermosin L, de Paz R, et al. Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications. Ann Hematol. 2015; 94(5): 779-787. DOI:10.1007/s00277-014-2274-y.

Balerdi A, Iglesias A, Olazabal I, Elicegui L, Duenas M, Puente M, et al. Is the autologous stem cell trasplantation in acute myelogenous leukemia a good option? Results of a single institution experience. Bone Marrow Transplant. 2015; 50(1): 5607-5608

Albaina O, Sahand IH, Brusca MI, Sullivan DJ, Fernandez de Larrinoa I, Moragues MD. Identification and characterization of nine atypical Candida dubliniensis clinical isolates. J Med Microbiol. 2015; 64(2): 147-156. DOI:10.1099/jmm.0.078832-0.

De La Fuente GF, Villegas AM, Nunez R, Gaya A, M, Bosch Josep M, et al. ACUTE AND CHRONIC RENAL FAILURE IN A COHORT OF PATIENTS IN THE SPANISH HPN REGISTRY. Haematologica. 2015; 100(4): 33-34

Ancin Arteaga I, Landeta E, Amarika I, Maruri N, Olivares N, Rinon M, et al. BABIES WITH ACUTE LEUKEMIA OF AMBIGIOUS LINEAGE AND T (4;11) (Q21;Q23)/ MLL-AF4 REARRANGEMENT. Haematologica. 2015; 100(4): 237-238

Landeta Callejo E, Amarika Ibarrondo I, Ancin Arteaga I, Pian Frances MA, Garcia Naveda L, Lopez Ariztegui MA, et al. ACUTE LEUKEMIAS OF AMBIGOUS LINEAGE IN A TERTIARY HOSPITAL. Haematologica. 2015; 100(4): 255-256

Carrano G, Lainz L, Olazabal I, Garcia Ruiz C, Cuetara MS, Sevilla MJ, et al. Antifungal activity of anti-Candida albicans germ tube antibodies (CAGTA) from patients with Invasive Candidiasis. Mycoses. 2015; 58(4, SI): 180-180

Villegas AM, Nunez R, Gaya A, Cuevas MV, Bosch JM, Carral A, et al. ACUTE AND CHRONIC RENAL FAILURE IN A PATIENT COHORT FROM THE SPANISH PNH REGISTRY. Haematologica. 2015; 100(1): 333-333

Posada Alcon L, Guerrero Fernandez L, Arrizabalaga Amuschategui B, Aragues Bornaechea P, Erkiaga Telleria S, Gomez Perez C, et al. CONGENITAL DEFICIT IN THE METABOLISM OF THE COBALAMIN AS A CAUSE OF PANCYTOPENIA. Haematologica. 2015; 100(4): 91-92

Arenillas Rocha L, Calvo Gonzalez X, Tormo Diaz M, Valcarcel Ferreiras D, Luno Fernandez E, Alonso Sanz E, et al. CONSIDERING THE PERCENTAGE OF BLASTS ON THE BASIS OF NON ERYTHROID CELLULARITY COULD IMPROVE THE CLASSIFICATION AND PROGNOSTIC EVALUATION OF THE MYELODYSPLASTIC SYNDROME (SMD) WITH EXCESS OF BALSTS. Haematologica. 2015; 100(4): 135-136

Talarn Forcadell C, Escoda Teigell L, Montesinos Fernandez P, Amutio Diez E, Pinan Frances MA, Gimenez Perez T, et al. ACUTE PROMYELOCYTIC LEUKEMIA VARIANT. INCIDENCE AND CHARACTERISTICS OF THE REPORTED CASES IN THE PEHTEMA-LPA CASE. Haematologica. 2015; 100(4): 144-144

Carlos Garcia Ruiz J, Olazabal I, Adan Pedroso RM, Lopez Soria L, Velasco Benito V, Antonio Sanchez Aparicio J, et al. Disseminated fusariosis and hematologic malignancies, a still devastating association. Report of three new cases. Rev Iberoam Micol. 2015; 32(3): 190-196. DOI:10.1016/j.riam.2014.11.003.

Calvo Gonzalez X, Arenillas Rocha L, Tormo Diaz M, Valcarcel Ferreiras D, Luno Fernandez E, Alonso Sanz E, et al. ERYTHROLEUKEMIA AND REFRACTORY ANEMIA WITH EXCESS OF BLASTS OF TYPE 1 (AREB-1) WITH ERYTHROID HYPERPLASIA SHARE CLINICAL- BIOLOGICAL CHARACTERISTICS AND PRESENT A SIMILAR PROGNOSIS. Haematologica. 2015; 100(4): 21-21

Gomez Perez C, Mateos Mazon JJ, Posada Alcon L, Vara Pampliega M, Diez Zubia H, Sierra Aisa C, et al. EVOLUTION OF GRAFT IN PATIENTS WHO BENEFIT FROM AUTOTRANSPLANT OF HEMATOPOIETIC PROGENITORS AND WHO HAVE BEEN MOBILIZED WITH PLERIXAFOR. Haematologica. 2015; 100(4): 222-222

Sierra Aisa C, Moreto Quintana A, Ancin I, Amarika I, Landeta E, Vara M, et al. MALLEOLAR ULCER BY HYDROXYUREA: THE MAKING OF AN EXHAUSTIVE HISTORY. Haematologica. 2015; 100(4): 286-287

Del Orbe Barreto R, Arrizabalaga B, Posada L, Moreno MI, Moran MJ. JAK-INHIBITORS COULD INDUCE HEPCIDIN DOWNREGULATION IN PATIENTS WITH MYELOFIBROSIS. Haematologica. 2015; 100(1): 759-759

Gutierrez Jomarron I, Luts I, Lopez Rubio M, Morado M, Arrizabalga B, Beneitez D, et al. NATIONAL RECORD OF AUTOIMMUNE HAEMOLYTIC ANAEMIA: PRELIMINARY RESULTS. SPANISH GROUP OF ERYTHROPATHOLOGY. Haematologica. 2015; 100(4): 84-85

Uresandi Iruin A, Vara M, Mateos Mazon JJ, F, Garcia Ruiz JC. RESULT OF THE DETERMINATION AND DIRECT COOMBS (CD) IN SAMPLE OF CORD OF THE NEW BORN (RN) WITHIN THE PROGRAM OF PREVENTION OF HEMOLYTIC DISEASE OF THE NEW BORN (EHRN). Haematologica. 2015; 100(4): 231-231

Del Orbe Barreto R, Arrizabalaga B, Manco L, Bento C, Ribeiro L, Garcia Ruiz JC. SEVERE NEONATAL JAUNDICE DUE TO A DE NOVO GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENT CLASS I MUTATION. Haematologica. 2015; 100(1): 587-587

Del Orbe Barreto R, Arrizabalaga B, De la Hoz AB, Tejada I, Araguees P, Silva C, et al. THE "NEXT GENERATION SEQUENCING" UTILITY IN THE OPTIMIZATION OF THE DIAGNOSIS OF THE CONGENITAL HEMOLITICAS ANEMIA. Haematologica. 2015; 100(4): 1-2

Vara Pampliega M, Diez H, Moreto A, Sierra C, Pinan MA, Iruin G, et al. TECHNIQUES OF MOLECULAR BIOLOGY APPLIED TO ESSENTIAL THROMBOCYTHEMIA (ET): DETERMINATION OF THE MUTATIONS JAK2 V617F AND CALRETICULIN. EXPERIENCE OF A HOSPITAL OF TERTIARY LEVEL. Haematologica. 2015; 100(4): 282-282

Saumell SS, Florensa LF, Rodriguez Rivera MR, Pedro CP, Maria Hernandez Rivas JM, Lumbreras EL, et al. Fluorescence in situ hybridization analysis does not increase detection rate for trisomy 8 in chronic myelomonocytic leukemia. Leuk Lymphoma. 2015; 56(1): 242-243. DOI:10.3109/10428194.2014.914197.

Arenillas L, Calvo X, Tormo M, Valcarcel D, Luno E, Alonso E, et al. Myelodysplastic Syndromes (MDS) with Erythroid Hyperplasia: Enumerating Blasts from Non-Erythroid Cell Compartment Improves the Risk Stratification of MDS with Excess of Blasts. Blood. 2015; 126(23)

Calvo X, Arenillas L, Tormo M, Valcarcel D, Luno E, Alonso E, et al. RAEB-1 with Erythroid Hyperplasia and Erythroleukemia Share Clinico-Biological Features and Outcome: A Same Disease with Different Labels?. Blood. 2015; 126(23)

Manuel Alonso Dominguez J, Casado F, Gomez Casares M, Buno I, Ferrer Marin F, Anguita E, et al. Measurement of PTCH1 Expression at Diagnosis Is an Appropriate Tool for Tyrosine Kinase Inhibitors Selection in Chronic Myeloid Leukemia Patients in Chronic Phase. Blood. 2015; 126(23)

Nomdedeu M, Galvo X, Costa D, Arnan M, Pomares H, Sanz G, et al. Disease-Attributable Mortality in the Myelodysplastic Syndromes (MDS): A Study from the Spanish MDS Cooperative Group (GESMD). Blood. 2015; 126(23)

Arenillas L, Calvo X, Tormo M, Valcarcel D, Luno E, Alonso E, et al. CONSIDERING PERCENTAGE OF BLASTS ON THE BASIS OF NON-ERYTHROID COMPARTMENT MIGHT IMPROVE THE CLASSIFICATION AND PROGNOSTICATION OF MDS WITH EXCESS OF BLAST CELLS. Leuk Res. 2015; 39(1): 130-131. DOI:10.1016/S0145-2126(15)30261-7.

Piñán MA, Ardanaz MT, Guinea JM, García Ruiz JC. Myeloid sarcoma preceding an acute promyelocytic leukaemia with neuromeningeal infiltration. Ann Hematol. 2014; 93(2): 339-340. DOI:10.1007/s00277-013-1795-0.

Brusca MI, Verdugo F, Amighini C, Albaina O, Moragues MD. Anabolic steroids affect human periodontal health and microbiota. Clin Oral Investig. 2014; 18(6): 1579-1586. DOI:10.1007/s00784-013-1126-9.

Sanchez Garcia J, del Canizo C, Lorenzo I, Nomdedeu B, Luno E, de Paz R, et al. Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion. Br J Haematol. 2014; 166(2): 189-201. DOI:10.1111/bjh.12876.

Rojas SM, Diez Campelo M, Luno E, Cabrero M, Pedro C, Calabuig M, et al. Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis. Leuk Res. 2014; 38(3): 304-309. DOI:10.1016/j.leukres.2013.11.005.

Puiggros A, Venturas M, Salido M, Blanco G, Fernandez Rodriguez C, Collado R, et al. Interstitial 13q14 Deletions Detected in the Karyotype and Translocations with Concomitant Deletion at 13q14 in Chronic Lymphocytic Leukemia: Different Genetic Mechanisms but Equivalent Poorer Clinical Outcome. Genes Chromosomes Cancer. 2014; 53(9): 788-797. DOI:10.1002/gcc.22188.

Del Orbe R, Pinan A, Zamora M, Landeta E, Amarika I, Amutio E, et al. BCR-ABL1 RATIO LOG REDUCTION IS A BETTER PREDICTOR OF MAJOR MOLECULAR RESPONSE (MMR) THAN 10% RATIO CUT-OFF AT 3 MONTHS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS. Haematologica. 2014; 99(1): 78-78

Garcia Gutierrez V, Maestro B, Cervantes F, Lopez Lorenzo JL, Martin Mateos ML, Alvarez A, et al. CLINICAL EXPERIENCE OF BOSUTINIB UNDER COMPASIONATE USE PROGRAM IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH RESISTANCE OR INTOLERANCE TO IMATINIB, DASATINIB AND NILOTINIB. Haematologica. 2014; 99(1): 337-338

Amutio E, Del Orbe RA, Amarika I, Landeta E, Zamora ME, Puente M, et al. TAILORED THERAPY FOR ADVANCED-STAGE HODGKIN LYMPHOMA, GUIDED BY INTERIM 18FDG-PET, WITH BEACOPP-ESCALATED FOLLOWED BY ABVD REGIMEN DECREASES REFRACTORY DISEASE RATES. Haematologica. 2014; 99(1): 676-677

Pombar Gomez M, Echebarria A, Bilbao Aldaiturriaga N, Pinan MA, Uriz J, Garcia Miguel P, et al. GENETIC VARIANTS IN VINCRISTINE TRANSPORTERS AS NEUROTOXICITY MARKERS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA. Pediatr Blood Cancer. 2014; 61(2): 172-172

Dolores Moragues M, Rementeria A, Jesus Sevilla M, Eraso E, Quindos G. Candida antigens and immune responses: implications for a vaccine. Expert Rev Vaccines. 2014; 13(8): 1001-1012. DOI:10.1586/14760584.2014.932253.

Saez Roson A, Sevilla M, Moragues M. Identification of superficial Candida albicans germ tube antigens in a rabbit model of disseminated candidiasis. A proteomic approach. Int Microbiol. 2014; 17(1): 21-29. DOI:10.2436/20.1501.01.204.

Garcia Noblejas A, Conde E, Martin A, Jesus Vidal M, Rojas R, Grande C, et al. Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma: A Retrospective Study of the Geltamo Group (1994-2011). Blood. 2014; 124(21)

Ardizzoni A, Posteraro B, Baschieri MC, Bugli F, Saez Roson A, Manca L, et al. AN ANTIBODY REACTIVITY-BASED ASSAY FOR DIAGNOSIS OF INVASIVE CANDIDIASIS USING PROTEIN ARRAY. Int J Immunopathol Pharmacol. 2014; 27(3): 403-412. DOI:10.1177/039463201402700310.

Mateos Mazon JJJ, Vara Pampliega M, Uresandi A, Parra I, Landeta E, Zuazua Verde FI, et al. BELOW WHAT NUMBER OF CD34+/UL CELLS ON THE 4TH DAY OF MOBILIZATION, IN MM PATIENTS MOBILIZATED WITH G-CSF ALONE, WE EXPECT A FAIL OF HEMATOPOIETIC STEM CELL COLLECTION. Bone Marrow Transplant. 2014; 49(1): 527-528

Garcia-Vazquez MD, Morales MC, Mateos-Mazon JJ, Ayestaran J, Fernandez-Conti P, Gomez-Coloma A, et al. Pathology of donor, harvest site and culture medium could determinate mesenchymal stem cell properties. Hum Gene Ther. 2013;24:101. FI: 4,019(Q1). ( Meeting Abstract)

Brusca MI, Verdugo F, Amighini C, Albaina O, Moragues MD. Anabolic steroids affect human periodontal health and microbiota.Clin Oral Investig. 2013 Nov 13.[Epub ahead of print]. FI: FI: 2,200(Q1)

García-Ruiz JC, López-Soria L, Olazábal I, Amutio E, Arrieta-Aguirre I, Velasco-Benito V, et al. Invasive infections caused by Saprochaetecapitata in patients with haematological malignancies: Report of five cases and review of the antifungal therapy. Rev IberoamMicol. 2013;30:248-55. FI: 1,312(Q3)

Arrieta-Aguirre I, Garcia-Ruiz JC, Lopez-Soria L, Olazabal I, Amutio E, Velasco-Benito V, et al. Molecular identification of Magnusiomycescapitatus from paraffinized tissue samples.Mycoses. 2013;56: 81-2. FI: 2,247(Q2). ( Meeting Abstract)

Saez Roson A, Ardizzoni A, Baschieri MC, Bugli F, Sterbini F,  Paroni Orsi CF, et al. Diagnostic utility of a microarray based on 11 proteins of Candida albicans for the diagnosis of invasive candidiasis. Mycoses.2013;56:78-9. FI: 1,278(Q3). ( Meeting Abstract)

Gutierrez-Camino A, Lopez-Lopez E, Martin-Guerrero I, Garcia-Miguel P, Sanchez-Toledo J, Carbone Baneres A, et al. New susceptibilitymarkers of childhoodacutelymphoblasticleukemia: microrna-relatedpolymorphisms. Ped Blood Cancer. 2013;60:58-9. FI: 2,353(Q1). ( Meeting Abstract).

Amutio E, Olivares M, Arambarri S, del Orbe R, Zamora M, Puente M, et al. Autologous stem cell transplantation in young and fit patients with diffuse large B-cell lymphomas. When to do it?.Bone Marrow Transpl. 2013;48:434-5. FI: 3,541(Q2). ( Meeting Abstract).

Mateos-Mazon JJ, Zamora M, Del Orbe R, Etxeguren I, Olivares M, Uresandi A, et al. Is bortezomib harmful to haemopoietic stem cells in patients with multiple myeloma? Effects on the mobilization of haemopoietic stem cells in patients treated with bortezomib versus non-bortezomib-based induction regimens in multiple myeloma. Bone Marrow Transpl. 2013;48:193. FI: 3,541(Q2). ( Meeting Abstract).

Gainza-Cirauqui ML, Nieminen MT, Novak Frazer L, Aguirre-Urizar JM, Moragues MD, Rautemaa R. Production of carcinogenic acetaldehyde by Candida albicans from patients with potentially malignant oral mucosal disorders . J Oral Pathol Med. 2013;42:243-9. FI: 2,055(Q1)

Lopez-Lopez E, Ballesteros J, Piñan MA, Sanchez de Toledo J, Garcia de Andoin N, Garcia-Miguel P, et al. Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia. Pharmacogenet Genomics. 2013;23:53-61. FI: 3,608(Q1)

Tesis del grupo

Autor/a: Ander Diez Villalba. Título: "Marcadores de infección por Candida albicans y su utilidad en el diagnóstico y protección frente a la candidiasis invasora". Directores/as: Dr. Iñigo Fernández de Larrinoa Santamaría, Dra. María Dolores Moragues Tosantos.

Autor/a: Inés Arrieta Aguirre. Título: "Diagnóstico molecular de especies de Candida y otras levaduras. Identificación de mutaciones en los genes ERG11, TAC1 y UPC2 en relación con la sensibilidad reducida a azoles, y a equinocandinas en el gen FKS". Director/a: Dra. Mª Dolores Moragues Tosantos.

Autor/a: Giulia Carrano. Título: "Characterization and evaluation of the antifungal activity of antibodies raised against Candida albicans germ tube in a rabbit model of infection and patients with Invasive Candidiasis". Director/a: Dra. Mª Dolores Moragues Tosantos.

Autor/a: Rafael Andrés Del Orbe Barreto. Título: Implementación de la Next Generation Sequencing en el diagnóstico de las Anemias Hemolíticas Congénitas. Director/a: Dra. Beatriz Arrizabalaga Amuchastegui, Dra. África García-Orad Carles. UPV/EHU

Autor/a: Aranzazu Sáez Rosón. Título: Caracterización de los anticuerpos anti-micelio de Candida albicans y biomarcadores para el diagnóstico de la candidiasis invasora. Director/a: Dra. María Dolores Moragues Tosantos. UPV/EHU

© 2022 IIS Biocruces Bizkaia